The Annual Physical Nobody Needs (and the One Worth Getting at 40)
Here is an uncomfortable finding that has been sitting in the literature for over a decade, largely unread by the people it concerns most.
A Cochrane systematic review pooled 17 randomized trials covering 251,891 people and asked whether general health checks — the annual physical, offered to adults not selected for any particular risk — reduce death. The answer: no effect on all-cause mortality, cardiovascular mortality, or cancer mortality (Krogsbøll et al., Cochrane Database of Systematic Reviews, 2019). They did produce more diagnoses and more treatment. They did not produce more living.
That result gets misread in both directions, so let's be precise about what it does and doesn't say. It does not say "don't see a doctor," and it does not say screening is useless — several individual screening tests have excellent evidence, and we'll list them. What it says is that the ritual — the yearly appointment as a general-purpose sweep, the head-to-toe exam on a healthy person, the reflexive broad panel — is not the thing that helps. The specific tests are what help, and they run on their own schedules, most of which are not annual.
The list that has earned its place
The U.S. Preventive Services Task Force grades screening tests by evidence: A and B mean do it (net benefit is at least moderate); C means offer selectively; D means don't — the harms outweigh the benefits; I means the evidence is insufficient to say. For an average-risk adult somewhere in the 35–70 range, the A and B list is short and unglamorous (all from the current USPSTF A and B recommendations):
- Blood pressure — all adults 18+. Grade A. The highest-yield measurement in preventive medicine, and the one most often taken badly. Insist it be done seated, back supported, feet flat, arm at heart level, after five quiet minutes — and repeated if the first reading is high.
- Lipids, in service of a statin decision — adults 40 to 75 with a cardiovascular risk factor and calculated risk ≥10%. Grade B.
- Prediabetes and type 2 diabetes — adults 35 to 70 with overweight or obesity. Grade B.
- Colorectal cancer — Grade A from 50 to 75, Grade B from 45 to 49. Colonoscopy is not the only acceptable method; stool-based tests done on schedule are also recommended options. The best test is the one you'll actually do.
- Lung cancer — annual low-dose CT for adults 50 to 80 with a 20 pack-year smoking history who currently smoke or quit within 15 years. Grade B. This is one of the highest-impact screenings in existence and it is badly underused.
- Breast cancer — biennial mammography, 40 to 74. Grade B (updated 2024).
- Cervical cancer — 21 to 65, every 3 years with cytology or every 5 years with HPV-based testing. Grade A. Note the intervals: this is a test that is actively worse when done annually.
- Hepatitis C — one-time screening, adults 18 to 79. Grade B. A curable infection that is usually silent for decades.
- HIV — adults 15 to 65. Grade A.
- Abdominal aortic aneurysm — one-time ultrasound, men 65 to 75 who have ever smoked. Grade B. Once. Not annually.
- Tobacco use (Grade A), depression (Grade B), and anxiety disorders in adults 64 and under (Grade B).
Look at what that list is made of: a few blood tests, a cuff, three or four cancer screenings on multi-year intervals, and some questions. Nearly all of it can happen without an annual head-to-toe examination. Almost none of it is what people picture when they picture "a physical."
The intervals are the point
Notice how few of these are yearly: colonoscopy every 10 years, cervical screening every 3–5, mammography every 2, AAA once ever, hepatitis C once ever. The annual cadence is an administrative and cultural artifact, not an evidence-based one. Doing an interval test more often than its interval doesn't add safety — it adds false positives, because every test run on a healthy person has a false-positive rate, and running it more often multiplies your exposure to it.
The honest "don't" list
Screening tests are not free even when they're covered. Every one carries a false-positive rate, a downstream cascade, and in some cases direct harm from the follow-up. These carry a formal Grade D — recommended against in asymptomatic adults:
- Screening ECG (resting or exercise) for cardiovascular risk in low-risk asymptomatic adults. Grade D. It very rarely changes anyone's risk category, and abnormal-looking-but-meaningless tracings launch stress tests and catheterizations that carry real risk.
- Carotid artery stenosis screening in asymptomatic adults. Grade D — harms outweigh benefits.
- Thyroid cancer screening in asymptomatic adults. Grade D. This one is the textbook case of overdiagnosis: screening finds enormous numbers of small cancers that would never have caused symptoms, and the surgery and lifelong hormone replacement that follow are permanent.
- Pancreatic cancer screening in asymptomatic adults. Grade D.
And a few that are graded more subtly but get sold as routine:
- PSA / prostate cancer screening. Grade C for ages 55–69 — meaning it should be an individual decision after a genuine conversation about benefits and harms, not a box auto-checked on a lab order. Screening roughly 1,000 men aged 55–69 over about 13 years prevents on the order of 1.3 prostate cancer deaths, alongside a well-documented burden of biopsies, overdiagnosis, and treatment side effects. For men 70 and older, it's Grade D. That's a real decision, and it deserves ten minutes, not a reflex.
- Vitamin D screening in asymptomatic adults. Grade I — insufficient evidence; the benefit-harm balance can't be determined. It appears on nearly every "wellness panel" sold.
The incidentaloma problem — the real cost of "scan everything"
The premium tier of the checkup industry is the whole-body MRI: no radiation, a couple of thousand dollars, and the promise of catching anything, anywhere, early.
Here is the arithmetic that promise leaves out. In a systematic review of whole-body MRI in asymptomatic subjects, the pooled prevalence of critical and indeterminate incidental findings was about 32%, with reported false-positive proportions around 16% (Kwee & Kwee, Journal of Magnetic Resonance Imaging, 2019). A separate meta-analysis of brain and body MRI in apparently asymptomatic adults put potentially serious incidental findings at about 3.9%, roughly half of them suspected malignancies (BMJ, 2018).
Translate that. Scan a room of a hundred healthy people and something like a third walk out with a finding that needs explaining. A handful will turn out to have something that genuinely mattered — that's the case for the scan, and it's not nothing. But the rest enter what radiologists call the diagnostic cascade: a repeat scan in three months, then six, sometimes a biopsy of a kidney or a thyroid or a lung nodule, occasionally a complication from that biopsy, and always months of living with an open question about your own body.
The word for this problem is overdiagnosis: finding something real, that is genuinely there, that was never going to hurt you — and then treating it, because once it's on a report nobody can comfortably ignore it. Overdiagnosis is invisible to the person it happens to. You never learn you were fine; you only ever experience "they caught it early." That asymmetry is why this industry grows regardless of evidence, and it is why no major guideline recommends whole-body screening of healthy adults.
So what is worth getting at 40?
A visit — just not the ritual one. What makes a checkup at 40 worth its cost is not the stethoscope on a healthy chest. It's these six things, and the honest truth is that most of them need time more than they need tests:
- A properly taken family history. Who, what, at what age. This single paragraph determines more of your plan than any panel — whether you need earlier colon screening, an Lp(a), a cardiology referral, or nothing extra at all. Most charts contain a useless version of it. (If your family history includes early heart disease, we've written the specific version: what to actually do when a parent died young.)
- Blood pressure, measured properly, more than once. Boring, free, and the leading modifiable cause of death worldwide.
- A lipid panel and a calculated cardiovascular risk estimate — ask for the number, and ask for the 30-year version, not just the 10-year. At 40 the 10-year number is almost always low and almost always misleading.
- The age-appropriate cancer screenings, started and scheduled. Colorectal starts at 45. Mammography at 40. Cervical continues on its interval. These are the interventions on the list with actual mortality evidence — and the most common failure isn't ordering the wrong test, it's never getting around to the right one.
- An honest conversation about the four things that actually determine your next thirty years — sleep, alcohol, activity, and mental health — with someone who has more than eleven minutes.
- A written answer about the tests you've seen advertised. Full-body MRI, the executive panel, the genetic risk score, the coronary CT. Not dismissed, and not sold — addressed by name for your situation: recommended, not recommended, or honestly uncertain, each with the reason.
That sixth item is the one nobody offers, and it's the one people actually want. The reason the "scan everything" clinic wins customers isn't that patients love MRIs. It's that the alternative on offer — a rushed twelve-minute visit that ends in "everything looks fine" with no accounting of what was and wasn't looked for — doesn't feel like an answer. Both options fail the same person for opposite reasons.
The bottom line
The annual physical, as a ritual, doesn't save lives — a quarter of a million randomized patients say so. A specific, short, age-appropriate list of screenings absolutely does. And the expensive middle ground being marketed to anxious 40-somethings mostly manufactures findings rather than preventing deaths.
What you want is depth where the evidence is, restraint where it isn't, and someone willing to write down which is which.
Real depth, and a written list of what not to scan
The Sane Physical is the third option: a physician-designed, guideline-based testing plan personal to your age, sex, and history — coordinated with what your own doctor already ordered so nothing is duplicated — plus a full physician hour on your results, not a portal message. And the part no one else writes: the "what NOT to scan, and why" review, addressing every tempting advertised test by name for your specific situation. When your situation genuinely warrants an advanced test, it's on the list. When it doesn't, we tell you what the ad didn't. ~$399 / year. No upsells, no ad trackers.
See what The Sane Physical includes →Launching soon — join the founding list for first access and 20% off for life.
Related Heartline reading: family history of early heart disease — the screening that's evidence-based and the screening that isn't. A diagnosis or recommended procedure you want independently checked — how to get a real second opinion without waiting weeks. A finding on a report that scared you — what "trace mitral regurgitation" actually means. And if you're reading your own chart — about 1 in 5 patients who do finds an error. All patient services: /early-access.
Heartline articles are educational and describe screening evidence in general — they are not medical advice, a diagnosis, a screening plan, or a substitute for care from your own physician, and reading them does not create a doctor-patient relationship. Screening recommendations depend on your individual age, sex, history, and risk factors, and change over time; those described here reflect published guidance current as of August 2026. Grades cited are U.S. Preventive Services Task Force grades for asymptomatic adults and do not apply to people with symptoms or known disease. If you have symptoms — chest pain, severe shortness of breath, fainting — call 911 or go to the nearest emergency department. Sources cited: Krogsbøll LT et al., "General health checks in adults for reducing morbidity and mortality from disease," Cochrane Database Syst Rev 2019; U.S. Preventive Services Task Force A, B, C, D and I recommendation statements; Kwee RM & Kwee TC, "Whole-body MRI for preventive health screening: a systematic review," J Magn Reson Imaging 2019; O'Sullivan JW et al., "Prevalence and outcomes of incidental imaging findings," BMJ 2018.